| Deutsch English Français Italiano |
|
<vpc9p9$3th3t$1@dont-email.me> View for Bookmarking (what is this?) Look up another Usenet article |
Path: news.eternal-september.org!eternal-september.org!.POSTED!not-for-mail From: JAB <here@is.invalid> Newsgroups: misc.news.internet.discuss Subject: Re: "Took It Did You? You're Boned" Date: Sat, 22 Feb 2025 04:43:50 -0600 Organization: A noiseless patient Spider Lines: 29 Message-ID: <vpc9p9$3th3t$1@dont-email.me> References: <vpbp1j$18b8t$1@news.mixmin.net> Reply-To: JAB <here@is.invalid> MIME-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit Injection-Date: Sat, 22 Feb 2025 11:43:53 +0100 (CET) Injection-Info: dont-email.me; posting-host="9ec6b09098a298d08712f4cab608ab50"; logging-data="4113533"; mail-complaints-to="abuse@eternal-september.org"; posting-account="U2FsdGVkX18utMg6mKeqrZmpRKCuCort" User-Agent: ForteAgent/8.00.32.1272 Cancel-Lock: sha1:BnpxMtf9lzPD6xTkdiz1SU7kTr8= On Sat, 22 Feb 2025 00:58:11 -0500, It's not a vax <fauci_is_a_fraud@niaid.nih.gov> wrote: >I warned people about the history of this technology before it was rolled >out in 2020 because it was not new technology and the prior science on it, >along with results, was available to anyone who cared to look. mRNA had >repeatedly failed on safety for cancer, where we tolerate ridiculously high >risk. A Vaccine For Pancreatic Cancer Continues To Show Promise Pancreatic cancer is notoriously difficult to treat, and about 90% of diagnosed patients die from the disease. A team at Memorial Sloan Kettering has been working to improve those outcomes by developing a new mRNA vaccine for pancreatic cancer. A few years ago, the team embarked on a small trial to test the vaccine's safety. Sixteen patients with pancreatic cancer received it, and even though it was a small study, the results were promising: Half the participants had an immune response, and in those patients the cancer hadn't relapsed after 18 months. This week, the team released a new study in Nature following those same patients, and found six out of eight who responded to the vaccine in the first study did not have their cancer return more than three years later. https://www.sciencefriday.com/segments/pancreatic-cancer-vaccine/